Curaderm Network
Curaderm BEC5 Eggplant Skin Cancer Cream by Dr. Bill Elliot Cham
Curaderm BEC5 Skin cancer treatment made from the extract of the eggplant and available (in some countries) for Non-Melanoma skin cancer & Sunspots as a cream in a topical cream. Since 1979 Curaderm-BEC5 has been performing ongoing research and clinical success with the the core technology which is a unique class of naturally occurring compounds.
Learn More about how to order Curaderm BEC5 Products
- Curaderm BEC5 is a simple, novel, elegant Skin Cancer Treatment, as Curaderm-BEC5 Cream is the only clinically proven treatment with 2 decades clinical experience for the treatment of BCCs, SCCs and Sunspots.
- Research that began in 1979 in Australia by Dr. Bill Cham has now been confirmed by a plethora of scientists world-wide. In particular the effective treatment of BCC with Curaderm-BEC5 has now been confirmed by ten independent centres in the United Kingdom. The Phase III and Phase IV Open Studies using Curaderm-BEC5 for the treatment of BCCs have concluded as follows:
“We consider that this rate of treatment success more than justifies the physician considering alternative to currently predominant treatments such as surgical excision or cryotherapy. In our view and experience [Curaderm] BEC5 is a topical preparation, which is safe and effective, ideal therapy for outpatient treatment.
Hence [Curaderm] BEC5 is a much needed alternative to surgery for basal cell carcinoma. This is the commonest cancer in Caucasions worldwide and the prevalence continues to increase with an increasing ageing population. It is a cost effective treatment for both primary and secondary skin cancer care.”
Learn More about how to order Curaderm BEC5 Products
Dr. Cham discovered and described a novel Mode of Action of BEC in selectively destroying cancer cells without harming normal cells (1990).
BEC the Anti Cancer Agent
- Specific endogenous endocytic lectins (EELs) were found to be present at much higher concentrations in cancer cells relative to normal cells.
- These EELs were present on the cell surface as receptors which recognized and bound the sugar moiety, in particular the rhamnose sugar (1990).
- BEC was subsequently internalized in the cancer cell and became lysosomotropic and consequently autolysis occurred.
- The disintegrated lysosome resulted in apoptosis of the affected cancer cells.
BEC was also shown to induce cell apoptosis by modulating tissue necrosis factor (TNF) (2004).
BEC has produced an effective and safe topical cream (Curaderm BEC5) for the treatment of non melanoma skin cancers and actinic (solar) keratoses. The same manufacturer, Curaderm Global, has also recently released a Sunscreen formulation using the same active ingredients and other natural ingredients to effectively eliminate any chance of new pre-cancer cells growing after sun exposure.
Curaderm.net vision is to continue to effectively commercialize Curaderm BEC5 via a network covering the global market and to arrange information on other equally important safe medical advancements
The extended range includes products in a wide variety of categories. Via the network, over 140 products range is focussed on Anti-Aging Health Technologies. Unique products, of life changing significance.





